Broadleaf Partners’s Alerian MLP ETF AMLP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-44,268
Closed -$1.88M 58
2019
Q4
$1.88M Buy
44,268
+1,455
+3% +$61.1K 1.03% 35
2019
Q3
$1.96M Buy
42,813
+2,344
+6% +$111K 1.22% 34
2019
Q2
$1.99M Buy
40,469
+3,703
+10% +$183K 1.27% 32
2019
Q1
$1.84M Buy
36,766
+908
+3% +$44.5K 1.29% 31
2018
Q4
$1.56M Buy
35,858
+1,134
+3% +$55.6K 1.25% 32
2018
Q3
$1.85M Buy
34,724
+3,706
+12% +$200K 1.24% 33
2018
Q2
$1.57M Buy
31,018
+2,911
+10% +$148K 1.15% 36
2018
Q1
$1.32M Buy
28,107
+5,416
+24% +$290K 1.01% 34
2017
Q4
$1.22M Buy
+22,691
New +$1.21M 1.02% 33

Other funds holding AMLP

Broadleaf Partners's AMLP Position: Q1 2020 in Review

Broadleaf Partners sold out of Alerian MLP ETF (AMLP) in Q1 2020, closing a stake of 44,268 shares — an estimated $1.88M sold.

Broadleaf Partners first reported a position in AMLP in Q4 2017 and held it in 9 quarters. The position peaked at $1.99M in Q2 2019. 613 funds tracked by Wall St. Rank hold AMLP as of Q1 2020.

  • Broadleaf Partners reported no remaining Alerian MLP ETF position as of Q1 2020 after selling out during the quarter.
  • Broadleaf Partners sold 44,268 Alerian MLP ETF shares in Q1 2020, an estimated $1.88M.
  • Broadleaf Partners first reported a position in Alerian MLP ETF in Q4 2017 and held it in 9 quarters.
  • Broadleaf Partners's Alerian MLP ETF position peaked at $1.99M in Q2 2019.
  • 613 funds tracked by Wall St. Rank held Alerian MLP ETF as of Q1 2020.

Based on Broadleaf Partners's 13F filing for Q1 2020, filed 5 May 2020.